Cleared Traditional

K052188 - CUTANEOUS ELECTRODE

K052188 is an FDA 510(k) clearance for CUTANEOUS ELECTRODE, manufactured by Rhythmlink International, LLC. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 12-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2005
Decision
12d
Days
Class 2
Risk

K052188 is an FDA 510(k) clearance for the CUTANEOUS ELECTRODE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Rhythmlink International, LLC (Columbia, US). The FDA issued a Cleared decision on August 23, 2005 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Rhythmlink International, LLC devices

FDA 510(k) Submission Details - K052188

510(k) Number K052188 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2005
Decision Date August 23, 2005
Days to Decision 12 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
137d faster than avg
Panel avg: 149d · This submission: 12d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Citech
ROBERT MOSENKIS

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 342
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K052188.
INTERX500 FLEXIBLE ARRAY ELECTRODE
K053626 · Neuro Resource Group, Inc. · Mar 2006
PROSTIM REUSABLE NEUROSTIMULATION ELECTRODES
K052875 · Summit Manufacturing, LLC · Dec 2005
THERAKNIT GARMENT ELECTRODE
K053214 · Neurotron Medical · Dec 2005
AMBU NEUROLINE GROUND
K051529 · Ambu, Inc. · Aug 2005
EZ-STIK ELECTRODES
K050469 · Naimco, Inc. · May 2005
EVERLIFE
K050788 · Everlife Medical Instrument Co., Ltd. · May 2005